The study for determining the drug resposible for perioperative anaphylaxis by using skin test and flow cytometry

The study for determining the drug resposible for perioperative anaphylaxis by using skin test and flow cytometry - The study for determining the drug resposible for perioperative anaphylaxis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021505

Enrollment

Registered

2016-03-25

Start date

2016-03-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anaphylaxis

Interventions

Skin test and flow cytometry will be performed once per subject. Drugs using for these tests will be different depending on cases.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patient 15 years or older, who underwent general or spinal anesthesia or their next of kin 2) The patient with perioperative anaphylaxis 3) The patient whose consent has been obtained in writing with respect to participation in this study

Exclusion criteria

Exclusion criteria: 1)The pregnant woman /The patient who has a possibility of pregnancy 2)The patient taking beta blocker 3)The patient taking steroid 4)The patient to whom a doctor judged inappropriate for participating in this study

Design outcomes

Primary

Measure	Time frame
Identifying the drug responsible for perioperative anaphylaxis	—

Countries

Japan

Contacts

Public ContactNoriko Seki

Saiseikai Maebshi Hospital Crinical Reserch Center

totemkopf@hotmail.co.jp027-252-6011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026